Table 3 Expression of HMGB1 in correlation with clinicopathologic variables.
From: Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas
Variables | cases(n) | HMGB1 low < 9 | HMGB1 high(≥ 9) | Significance(P) | ||
|---|---|---|---|---|---|---|
(n=) | (%) | (n=) | (%) | |||
Total | 78 | 46 | 59.0 | 32 | 41.0 | |
Gender | ||||||
Male | 55 | 29 | 52.7 | 26 | 42.3 | 0.129 |
Female | 23 | 17 | 73.9 | 6 | 26.1 | |
Age at surgery | ||||||
≤ 60 | 44 | 29 | 65.9 | 15 | 34.1 | 0.111 |
> 60 | 34 | 16 | 47.1 | 18 | 52.9 | |
Tumor differentiation | ||||||
G1 | 9 | 1 | 11.1 | 8 | 88.9 | 0.012 |
G2 | 29 | 21 | 72.4 | 8 | 27.6 | |
G3 | 27 | 17 | 67.0 | 10 | 37.0 | |
G4 | 13 | 7 | 53.8 | 6 | 46.2 | |
Tumor stage | ||||||
Stage I + II | 35 | 23 | 65.7 | 12 | 34.3 | 0.356 |
Stage III + IV | 43 | 23 | 53.5 | 20 | 46.5 | |
pT stage | ||||||
pT1-2 | 12 | 9 | 75.0 | 3 | 25.0 | 0.340 |
pT3-4 | 66 | 37 | 56.1 | 29 | 43.9 | |
Nodal status | ||||||
pN0 | 34 | 23 | 67.6 | 11 | 32.4 | 0.246 |
pN1~3 | 44 | 23 | 52.3 | 21 | 47.7 | |